第四届全球制药前沿(中国)论坛2012
2012.6.6-8 | 上海
行业领域:制药行业、新药研发
会议类型:论坛、研讨会、科技成果转化大会
会议主题:把握“十二五”重大新药创制的机遇,推动产学研合作,加速新药研发进程及科技成果转化
会议名称:第四届全球制药前沿(中国)论坛暨新药科技成果转化及项目洽谈大会
基本信息
会议时间: 2012年6月6日至2012年6月8日
会议地点: 上海
会议主题: 把握“十二五”重大新药创制的机遇,推动产学研合作,加速新药研发进程及科技成果转化
会议规模: 200-250人
大会邀请嘉宾:
Ruiping Dong, Senior Vice President, Head of Emerging Market,Merck & Co
Jingwu Zang, Senior Vice President, Head of R&D China,GlaxoSmithKline
Arjun Oberoi, Vice President, Strategy & Business Development,Sanofi
Kuiling Ding, Director-General,Shanghai Institute of Organic Chemistry, CAS
Scott Simonet, Vice President, Metabolic Disorders Therapeutic Area, Amgen
Zhong Zhong, Senior Director of Discovery Technology, GlaxoSmithKline
Mingwei Wang, Director,The National Center for Drug Screening
Alexander Mayweg, Head of Discovery Chemistry & Metabolic Chemistry Section,Roche R&D Center China
Yi Yang, Head of Pre-Clinical Safety, China R&D, Director of Drug Safety Evaluation,Sanofi
Gary Gintant, Senior Group Leader, Department of Integrative Pharmacology, Global Pharmaceutical Research & Development,Abbott Laboratories
Clive Wood, Senior Vice President and Head of Global Biologics,Bayer HealthCare
Michael Shi, Senior Director, Biomarker Project Leader, Oncology Translational Medicine ,Novartis
Vincenzo Teneggi,Head of Early Development & Clinical Pharmacology, Asia Pacific, Roche R&D Center China
联系人: Shirley Zhang
联系电话: 86-21-5192 0620
电子邮箱: shirleyzh@innchinc.com
官方网站: http://www.innchinc.com/wpcs/
分享到